Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series

Abstract

This is the first report in the literature demonstrating that ivabradine appears to be a well tolerated agent, which should be considered as a symptomatic treatment of clozapine-induced tachycardia if the use of a β blocker fails due to a lack of response or intolerability.